Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.

Acta pharmacologica Sinica - 1 Mar 2003

Zhang Zhi-Jun, Yao Zhi-Jian, Zhang Xiao-Bin, Chen Jian-Fang, Sun Jing, Yao Hui, Hou Gang, Zhang Xin-Bao

Abstract excerpt

AIM: To investigate whether there is an association of antipsychotic agent-induced weight gain with the TaqI A polymorphism of dopamine D2 receptor (DRD2) gene and therapeutic response to antipsychotic treatment in schizophrenia. METHODS: Genotyping was performed using the PCR-RFLP techniques in a total of 117 first-episode Chinese Han schizophrenic patients (mean age 26+/-8 a; 58 male, 59 female). Moreover, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genotype

Share to Polymorphism, Restriction Fragment Length

Share to Receptors, Dopamine D2

Share to Schizophrenia

Share to Weight Gain

Source

Identifiers

PMID: 12617772

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.PMID 12617772Read ↗

[No association of -1438G/A polymorphism in promoter region of 5-HT2A receptor gene with antipsychotic agent-induced weight gain].Semantic proximity Read ↗

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.Semantic proximity Read ↗

Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.Semantic proximity Read ↗

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.Semantic proximity Read ↗

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gainSemantic proximity Read ↗

[Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain].Semantic proximity Read ↗

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophreniaSemantic proximity Read ↗

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.Semantic proximity Read ↗

[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].Semantic proximity Read ↗

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.Semantic proximity Read ↗

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.Semantic proximity Read ↗

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.